BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8530572)

  • 1. Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results.
    Rittmaster RS
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3403-5. PubMed ID: 8530572
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E; Janni A; Lobo RA
    J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
    Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy.
    Morcos RN; Abdul-Malak ME; Shikora E
    Fertil Steril; 1994 Mar; 61(3):427-31. PubMed ID: 8137961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis.
    Gargiulo AR; Hornstein MD
    Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1716-22. PubMed ID: 7989480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Add-back" therapy for endometriosis in adolescents.
    Lubianca JN; Gordon CM; Laufer MR
    J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
    Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
    Simberg N; Tiitinen A; Silfvast A; Viinikka L; Ylikorkala O
    J Clin Endocrinol Metab; 1996 Feb; 81(2):646-51. PubMed ID: 8636283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen-progesterone "add-back" for long-term GNRH analogue therapy].
    Levy T; Ben-Rafael Z
    Harefuah; 1995 Jun; 128(12):789-92. PubMed ID: 7557691
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical applications of gonadotropin-releasing hormones in reproductive disorders.
    Moghissi KS
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):125-40. PubMed ID: 1576979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL; Monroe SE; Jaffe RB
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of endometriosis].
    Wenzl R; Jirecek S; Huber J
    Wien Med Wochenschr; 1999; 149(13):372-3, 376. PubMed ID: 10568019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hirsutism.
    Alsantali A; Shapiro J
    Skin Therapy Lett; 2009 Sep; 14(7):1-3. PubMed ID: 20039595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative effects of the administration of cortisone, estrogen-progestin, and placebo on the clinical manifestations of the polycystic ovary (Stein-Leventhal) syndrome.
    Benjamin F; Kolodny HD; Schwartz ED
    J Reprod Med; 1971 Jun; 6(6):266-9. PubMed ID: 4255649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The ranking of the gestagens in the treatment of pain caused by endometriosis--an overview].
    Schweppe KW
    Zentralbl Gynakol; 2003; 125(7-8):276-80. PubMed ID: 14505263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.